Testing effectiveness (Phase 2)Study completedNCT05454410
What this trial is testing
Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)
Who this might be right for
Treatment-Resistant Depression
Novartis Pharmaceuticals 60